AbbVie Inc. (NYSE:ABBV) closed its last session at $113.08

11

AbbVie Inc. (NYSE:ABBV) closed its last session at $113.08. The stock traded within a range of $110.28 and $113.67. The company operates in the Healthcare sector with a market capitalization of 180.59 Million. Trading volume for AbbVie Inc. was 6.18 Million in its previous trading session. Currently, AbbVie Inc. (NYSE:ABBV) has an average volume of 5.76 Million.

Company Profile

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie aims to help patients’ live healthier lives and collaborate on sustainable healthcare solutions.

Analyst Views

AbbVie Inc. (NYSE:ABBV) received a Buy rating from 3 analysts. 0 analysts gave its stock an Outperform rating. 2 analysts say it’s a Hold while 1 analysts provided their expert opinion as Sell.

AbbVie Inc. (NYSE:ABBV) touched its 1-Year High price of $125.86 on 01/26/18 and its 1-Year Low price of $ 60.40 on 02/16/17.

EPS & Financials

AbbVie Inc. (NYSE:ABBV) reported its EPS in the last quarter as $1.48/Share beating the analyst estimate of $1.44/Share by a difference of $0.04. This showed a surprise of 2.8% in the last quarter earnings.

For the current quarter, 15 analysts are projecting a mean EPS of $1.78/share. According to their observations and findings, the stock could provide a high EPS of $1.81/share and a low EPS of $1.72/share.

Analysts believe that the company has the potential to earn average revenue of $7.53 Billion for the current quarter. According to their predictions high & low revenue estimates are 7.69 Billion and 7.38 Billion respectively.

Technical Analysis

By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with HIGH volatility. AbbVie Inc. (NYSE:ABBV) has a 20-Day average volume of 8.63 Million. According to today’s trading volume AbbVie Inc. is BELOW its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BEARISH territory while an analysis of the last 40-Day trend shows a BULLISH signal. The 100-Day trend also shows a BULLISH trend as well.

The company currently has an insider ownership of 0.07 Percent and Institutional ownership of 73.4 Percent. The return on assets stands at 9.8%, Return on Equity currently is 117.9% and the Return on Investment value is 18%.

AbbVie Inc. (NYSE:ABBV) gross margin percentage stands at 76.5% while its operating margin for the past trailing twelve month is 36 percent and its overall profit margin (ttm) is 24.1 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 1.8% with a 50-Day Simple Moving Average of 9.63 percent. As of today, the company has a SMA200 (200-day simple moving average) of 33.34 Percent. The Stock has YTD (year to date) performance of 16.93 percent.

The TTM operating margin for the company stands at 36%. The return on invested capital is at 18%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 40.62.

The company’s stock is currently moving with a +ve distance from the 200 day SMA of approximately 33.34%, and has a solid year to date (YTD) performance of 16.93% which means that the stock is constantly adding to its value from the previous fiscal year end price.